Patents by Inventor Pietro Ciceri
Pietro Ciceri has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 10324092Abstract: Provided herein are nucleic acid tags that are linked to, or capable of linking to, a protein of interest. In particular, the nucleic acid tags are oligonucleotides comprising a reporter function and a protein tagging function. Also provided herein, are nucleic acid tag compositions, kits and methods of use thereof.Type: GrantFiled: July 28, 2015Date of Patent: June 18, 2019Assignee: Eurofins DiscoverX CorporationInventors: Pietro Ciceri, Jeremy Hunt, Jean-Michel A. Lelias, Mike Morrison, Daniel K. Treiber, Lisa Wodicka
-
Publication number: 20150377886Abstract: Provided herein are nucleic acid tags that are linked to, or capable of linking to, a protein of interest. In particular, the nucleic acid tags are oligonucleotides comprising a reporter function and a protein tagging function. Also provided herein, are nucleic acid tag compositions, kits and methods of use thereof.Type: ApplicationFiled: July 28, 2015Publication date: December 31, 2015Inventors: Pietro Ciceri, Jeremy Hunt, Jean-Michel A. Lelias, Mike Morrison, Daniel K. Treiber, Lisa Wodicka
-
Patent number: 9110054Abstract: Provided herein are nucleic acid tags that are linked to, or capable of linking to, a protein of interest. In particular, the nucleic acid tags are oligonucleotides comprising a reporter function and a protein tagging function. Also provided herein, are nucleic acid tag compositions, kits and methods of use thereof.Type: GrantFiled: June 29, 2007Date of Patent: August 18, 2015Assignee: DiscoveRx CorporationInventors: Pietro Ciceri, Jeremy Hunt, Jean-Michel A. Lelias, Mike Morrison, Daniel Treiber, Lisa Wodicka
-
Patent number: 7897381Abstract: The present invention provides an advance in phage display technology by permitting the uncoupling of the propagation of phages containing inserted sequences encoding heterologous polypeptides from the expression of said polypeptides. The invention provides phage constructs and methods for their use to permit phage coat protein expression, and thus phage propagation, in the absence of display of heterologous polypeptides, which may be expressed as a fusion with said coat protein in a regulated manner.Type: GrantFiled: October 31, 2007Date of Patent: March 1, 2011Assignee: Ambit Biosciences CorporationInventors: Pietro Ciceri, Patrick Parvis Zarrinkar, Daniel Kelly Treiber, David J. Lockhart
-
Patent number: 7833741Abstract: The present invention provides an advance in phage display technology by permitting the uncoupling of the propagation of phages containing inserted sequences encoding heterologous polypeptides from the expression of said polypeptides. The invention provides phage constructs and methods for their use to permit phage coat protein expression, and thus phage propagation, in the absence of display of heterologous polypeptides, which may be expressed as a fusion with said coat protein in a regulated manner.Type: GrantFiled: September 22, 2006Date of Patent: November 16, 2010Assignee: Ambit Biosciences CorporationInventors: Pietro Ciceri, Patrick Parvis Zarrinkar, Daniel Kelly Treiber, David J. Lockhart
-
Publication number: 20090053701Abstract: Provided herein are nucleic acid tags that are linked to, or capable of linking to, a protein of interest. In particular, the nucleic acid tags are oligonucleotides comprising a reporter function and a protein tagging function. Also provided herein, are nucleic acid tag compositions, kits and methods of use thereof.Type: ApplicationFiled: June 29, 2007Publication date: February 26, 2009Applicant: Ambit Biosciences Corp.Inventors: Pietro Ciceri, Jeremy Hunt, Jean-Michel A. Lelias, Mike Morrison, Daniel Treiber, Lisa Wodicka
-
Publication number: 20080318298Abstract: The present invention provides an advance in phage display technology by permitting the uncoupling of the propagation of phages containing inserted sequences encoding heterologous polypeptides from the expression of said polypeptides. The invention provides phage constructs and methods for their use to permit phage coat protein expression, and thus phage propagation, in the absence of display of heterologous polypeptides, which may be expressed as a fusion with said coat protein in a regulated manner.Type: ApplicationFiled: October 31, 2007Publication date: December 25, 2008Applicant: Ambit Biosciences Corp.Inventors: Pietro Ciceri, Patrick Parvis Zarrinkar, Daniel Kelly Treiber, David J. Lockhart
-
Patent number: 7323490Abstract: The invention provides pyrrole-containing compounds and methods of use thereof. Kits and pharmaceutical compositions comprising the pyrrole compounds of the invention are also provided. The compounds and compositions disclosed herein are preferably used in the treatment of neurodegenerative diseases, cardiovascular diseases, proliferative diseases, and visual disorders. In particular, methods and compositions for the treatment of stroke are disclosed herein.Type: GrantFiled: May 17, 2004Date of Patent: January 29, 2008Assignee: Ambit Biosciences CorporationInventors: David J. Lockhart, Hitesh K. Patel, Zdravko V. Milanov, Shamal Anil Mehta, Patrick Parvis Zarrinkar, William H. Biggs, III, Pietro Ciceri, Miles A. Fabian, Daniel K. Treiber
-
Publication number: 20070105093Abstract: The present invention provides an advance in phage display technology by permitting the uncoupling of the propagation of phages containing inserted sequences encoding heterologous polypeptides from the expression of said polypeptides. The invention provides phage constructs and methods for their use to permit phage coat protein expression, and thus phage propagation, in the absence of display of heterologous polypeptides, which may be expressed as a fusion with said coat protein in a regulated manner.Type: ApplicationFiled: September 22, 2006Publication date: May 10, 2007Applicant: Ambit Biosciences CorporationInventors: Pietro Ciceri, Patrick Zarrinkar, Daniel Treiber, David Lockhart
-
Patent number: 7112435Abstract: The present invention provides an advance in phage display technology by permitting the uncoupling of the propagation of phages containing inserted sequences encoding heterologous polypeptides from the expression of said polypeptides. The invention provides phage constructs and methods for their use to permit phage coat protein expression, and thus phage propagation, in the absence of display of heterologous polypeptides, which may be expressed as a fusion with said coat protein in a regulated manner.Type: GrantFiled: August 7, 2002Date of Patent: September 26, 2006Assignee: Ambit Biosciences CorporationInventors: Pietro Ciceri, Patrick Parvis Zarrinkar, Daniel Kelly Treiber, David J. Lockhart
-
Publication number: 20050182125Abstract: The invention provides pyrrole-containing compounds and methods of use thereof. Kits and pharmaceutical compositions comprising the pyrrole compounds of the invention are also provided. The compounds and compositions disclosed herein are preferably used in the treatment of neurodegenerative diseases, cardiovascular diseases, proliferative diseases, neuroinflammatory disorders, vascular disorders with an inflammatory component, and visual disorders. In particular, methods and compositions for the treatment of stroke are disclosed herein.Type: ApplicationFiled: November 15, 2004Publication date: August 18, 2005Applicant: Ambit Biosciences CorporationInventors: David Lockhart, Hitesh Patel, Zdravko Milanov, Shamal Mehta, Patrick Zarrinkar, William Biggs, Pietro Ciceri, Miles Fabian, Daniel Treiber
-
Publication number: 20040259880Abstract: The invention provides pyrrole-containing compounds and methods of use thereof. Kits and pharmaceutical compositions comprising the pyrrole compounds of the invention are also provided. The compounds and compositions disclosed herein are preferably used in the treatment of neurodegenerative diseases, cardiovascular diseases, proliferative diseases, and visual disorders. In particular, methods and compositions for the treatment of stroke are disclosed herein.Type: ApplicationFiled: May 18, 2004Publication date: December 23, 2004Applicant: Ambit Biosciences CorporationInventors: David J. Lockhart, Hitesh K. Patel, Zdravko V. Milanov, Shamal Anil Mehta, Patrick Parvis Zarrinkar, William H. Biggs, Pietro Ciceri, Miles A. Fabian, Daniel K. Treiber